Skip to content

AUMOVIO's 3-board buy cluster after Q3 and BMW

BMW shares have had their own bruising year, but AUMOVIO’s latest print was the one that pushed its stock to a fresh low since the spin-off. Three board members then bought into the weakness, and that is the part worth reading against the sector, not in isolation.

By Insiders Trades Newsroom (automated brief, how it is made)9 min · 1,998 words

BMW, the low print, and why AUMOVIO is the one to watch

AUMOVIO is not being read in a vacuum. The stock was already under pressure after Q3, and the broader European auto supply chain is still dealing with weak production, EV margin strain, and competition from lower-cost Asian players. That is the backdrop. The filing only matters because it came after the market had already marked the name down hard, and because the buyers sit on the management board, not in some peripheral role.

The clean comparison is Continental. AUMOVIO came out of Continental’s orbit, and the market is still treating it like a supplier that has to prove itself quarter by quarter. Continental has shown some resilience in recent sessions, while AUMOVIO has been punished for sales decline and a softer top line. You can see the difference in how the market is pricing the two stories. Continental is still the older, broader industrial name. AUMOVIO is the newer, narrower one, and the burden of proof sits heavier on it.

The Q3 print that set the table

AUMOVIO’s November 5 results did the damage first. Adjusted sales came in at EUR 4.0 billion, down 12.0% year over year from EUR 4.5 billion. Adjusted EBIT was EUR 137 million, down 10.5% from EUR 153 million, although the adjusted EBIT margin edged up to 3.5% from 3.4%. Nine-month adjusted sales fell 9.8% to EUR 12.6 billion. The company kept full-year 2026 guidance in place, with adjusted sales of EUR 17.0 billion to EUR 17.5 billion, an adjusted EBIT margin of 3.0% to 4.0%, and normalized free cash flow of EUR 500 million to EUR 700 million.

The market did not reward the nuance. Shares fell about 7% on the results day to around EUR 31.35 to EUR 31.48, which marked a new low since the September 2025 spin-off from Continental AG. The stock was also down roughly 26% year to date. That matters because the insider buying did not happen after a euphoric rerating or a clean breakout. It happened after a drawdown, after a weak sales print, and after the market had already made its judgment.

+3.56%
Historical T+90 cohort return
Source, Insiders Trades cohort data

What the board bought, and why the size matters

The first name to note is Jean-François Tarabbia, whose purchase was the largest of the three. He bought about EUR 199,281, euro-normalised at ingest, on November 11, 2026. Dr. Boris Mergell bought about EUR 99,773, and Philipp von Hirschheydt bought about EUR 74,855. Together, the three purchases totaled roughly EUR 373,909. All three were management board members, and all three filed on the same day.

The size is not heroic. It is not a balance-sheet event. It is also not the sort of token trade you ignore. Our scoring puts the cluster at 4.6, and the reason is plain enough: it was filed by operating directors, it came as part of an insider cluster, and the filing values are small relative to AUMOVIO’s EUR 3.27 billion market value. That is the right scale to keep in mind. This was not a rescue trade. It was a board-level buy into weakness, after the market had already taken the stock down.

The cluster picture is a little richer than the three names in the headline. Insiders Trades data shows four recent declarations in the same window, including Dr. Ismail Dagli on November 6, also a buy. So the November 11 filings were not a one-off gesture. They sat inside a broader run of board-level buying. That does not make the stock cheap by itself. It does tell you the board is not standing aside while the market reprices the name lower.

AUMOVIO versus Continental, in one quarter and one trade

Continental is the useful foil because it shows what a more established supplier can look like when the market is less willing to punish every miss. AUMOVIO’s Q3 numbers were weaker on sales, and the stock got hit harder. Continental, by contrast, has had more room to absorb the same sector pressures because it is a larger, more diversified business with a longer public history. AUMOVIO does not have that cushion yet. The market is still asking whether the spin-off can stand on its own.

That is why the order intake line matters. AUMOVIO said order intake doubled to EUR 6.4 billion in the quarter, helped by a EUR 1.4 billion BMW supply agreement after a prior settlement. That is the one number in the release that gives the bulls something to work with. It says the company is still winning business, even while sales and EBIT are under pressure. It also explains why the board might be buying now rather than later. The market has been focused on the near-term revenue decline. Management is looking at the order book and the medium-term mix.

The comparison with Continental also cuts the other way. Continental is the older name with the broader base, but AUMOVIO is the one leaning more directly into sensors, brake systems, displays, driver-assistance technology, and software architectures for software-defined vehicles. That is where the industry is going, at least in theory. The problem is that the transition has not been kind to margins. Higher battery costs, lower per-unit profitability in EVs, and weaker production volumes are still squeezing suppliers. AUMOVIO is exposed to all of that, just with less history to lean on.

The sector is still the hard part of the story

The auto supplier backdrop is not helping. Mobility Global is forecasting around 91.6 million light vehicles for 2026, down 1.7% year over year, with North America and China both under pressure. AUMOVIO itself flagged raw-material and semiconductor cost headwinds in its release. Chinese competitors have also increased their European market share to 12.7% in Q3 2026, which is the kind of number that keeps European suppliers honest. The industry is not short of demand in the abstract. It is short of easy margin.

That is the context in which the board buying becomes interesting. If this were a clean cyclical rebound, the filing would be less informative. If this were a sector with obvious volume recovery, the trade would be easier to dismiss as routine confidence signaling. Instead, AUMOVIO is buying into a market that is still skeptical about European auto suppliers, still worried about EV economics, and still watching policy noise around emissions rules and trade measures. The stock is not being lifted by the sector. It is being tested by it.

European automakers and suppliers are also dealing with capital allocation pressure from elsewhere in the market. AI spending has pulled attention and money toward other themes, while traditional auto names have had to defend their relevance. That does not change AUMOVIO’s operating reality, but it does change the valuation conversation. A supplier with falling sales and a still-fragile margin profile has to earn a rerating the hard way. The board buying is a data point in that process, not the process itself.

What our cohort data says, and where it stops

Insiders Trades data for the relevant bucket, director-level buys at large-cap names, shows a 90-day win rate of 53.3% and an average return of 3.56%. The 365-day average return is 27.35%. That is the historical cohort data for this kind of filing, not a forecast for AUMOVIO and not a promise that this trade will work. It is useful because it tells you that board-level buying at larger names has not been a dead letter in our sample. It is not useful if you try to turn it into a guarantee.

The sample is large, with 31,275 observations, which is one reason the bucket is worth respecting. But the bucket is still a bucket. It does not know whether the company just printed a weak quarter, whether the stock has already been cut in half, or whether the board is buying because it sees a near-term catalyst in order intake. That is why the filing has to be read against the quarter, the sector, and the price action. A number on its own is just a number.

Our point-in-time backtest framework also sits behind the broader screen here, but the screen is not the thesis. The fundamental pillars are a transparent filter, not an alpha claim, and they are there to keep the noise down. AUMOVIO’s own internal score is 46, with quality at 36. That is middling, which fits the story. This is not a pristine quality compounder. It is a newly listed supplier with a board that is buying after a rough quarter and a market that is still unconvinced.

The valuation question the market is really asking

AUMOVIO’s market cap in the filing data is EUR 3.27 billion. That is not tiny, but it is small enough that a few board purchases can still register as a meaningful gesture. The market is not pricing this like a distressed balance-sheet story. It is pricing it like a company that has to prove its earnings power after the spin-off. That is a different burden. The stock can recover if sales stabilize and the order book converts, but the market will want evidence, not just guidance reaffirmation.

The analyst split tells you the same thing. Bernstein reiterated Outperform with a EUR 54 target, while Jefferies stayed Neutral. That spread is wide enough to show that the market is not settled on the name. The board buying does not resolve that split. It does, however, make the bearish case a little less comfortable. When three management board members buy after a weak quarter and a sharp selloff, you have to ask whether the market has already discounted too much of the bad news.

Still, the stock has to earn any rerating from here. The Q3 release gave the bulls one usable line, the doubled order intake, and one ugly line, the sales decline. The insider cluster sits between those two facts. It says the board is willing to buy into the gap between current earnings pressure and future order conversion. That is a real stance. It is also a stance that can be wrong if the sector stays weak for longer than management expects.

What to watch before the next filing window

The next useful check is not another slogan about confidence. It is whether AUMOVIO can turn the BMW-linked order intake into visible revenue stabilization, and whether the margin can hold near the 3.5% level it posted in Q3. The company confirmed 2026 guidance, so the market will now watch whether the next quarter shows any narrowing of the gap between order flow and reported sales. If that gap closes, the board buys will look better in hindsight. If it does not, the cluster will look more like a well-timed expression of internal patience than a decisive turn.

The other thing to watch is whether the stock can stop making fresh lows. The market already marked it down to around EUR 31.35 to EUR 31.48 after the results, and that was the lowest level since the spin-off. If the shares keep trading as if the quarter was worse than guidance suggests, then the board buying will remain a useful signal but not a decisive one. If the stock starts to stabilize while the order book remains strong, the comparison with Continental gets more interesting, because the newer name would be showing the kind of resilience the market has not yet priced in.

For now, the comparison is simple. Continental is the steadier reference point. AUMOVIO is the one with the sharper selloff, the weaker sales print, and the more visible insider buying cluster. The board has put money down after the quarter. The market still has to decide whether that is early or merely brave.

Sources and further reading

  1. Thebrakereportpress
  2. Marketscreenerpress
  3. Reuterspress
  4. Aumoviopress
  5. Seeking Alphapress
  6. Marketscreenerpress
  7. Eqs-newspress
  8. Quartrpress

This is not investment advice.

Mentioned in this story

CompanyAUMOVIO SEInsiderTarabbia, Jean-FrancoisInsidervon Hirschheydt, Philipp

Companies in the same sector and market

CompanyGEA Group Aktiengesellschaft

Act on this

SignalsToday's recommendationsScreenerInsider-signal screenerUniverseAll covered companies

Related reading